AFP and hepatocellular carcinoma: PCR score +: 9 of 16 (56%) untreated HCC patients, 1 of 31 (3%) CLD and 2 of 26 (7.6%) healthy subjects.15 patients with both PCR score and AFP available: 4 (27%) PCR score +, 1(7%) AFP +, 5 (33%) PCR score + and AFP +6 patients within Milan criteria: 2 (33%) PCR score + and 0 (0%) AFP +